Karen L. Smith, M.D., Ph.D., Executive Vice President, Chief Medical Officer of Emergent BioSolutions joined MTC CEO, Martin Rosendale for a discussion on developing and deploying COVID-19 vaccines and therapeutics. They discussed the supply chain and pipeline challenges, the value of collaboration in our region and Maryland as a premier vaccine industry cluster.
Karen L. Smith, M.D., Ph.D., Executive Vice President, Chief Medical Officer of Emergent BioSolutions joined MTC CEO, Martin Rosendale for a discussion on developing and deploying COVID-19 vaccines and therapeutics. They discussed the supply chain and pipeline challenges, the value of collaboration in our region and Maryland as a premier vaccine industry cluster.